Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28256553 | 0.98 | NPSR1 (0.46) | NPSR1MTNR1AMTNR1BALDH1A1KMT2A | |
| Sulfuric Acid SCHEMBL1626445 | 0.91 | L3MBTL1 (0.43) | NPSR1MTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL28088208 | 0.89 | SCN9A (0.44) | NPSR1MTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL9632432 | 0.88 | KEAP1 (0.51) | MTNR1AMTNR1BKMT2ANPC1RAB9A | |
| SCHEMBL2485185 | 0.88 | SCN9A (0.52) | MTNR1AMTNR1BKMT2ATSHRKCNH2 | |
| SCHEMBL11341409 | 0.88 | KEAP1 (0.45) | NPSR1MTNR1AMTNR1BNPC1HTT | |
| SCHEMBL5690847 | 0.88 | ALDH1A1 (0.52) | NPSR1MTNR1AMTNR1BALDH1A1KMT2A | |
| Toluene SCHEMBL9461781 | 0.88 | KEAP1 (0.44) | NPSR1MTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL2484595 | 0.88 | CACNA2D1 (0.49) | NPSR1ALDH1A1KMT2ANPC1POLB | |
| SCHEMBL329646 | 0.85 | NPSR1 (0.48) | NPSR1MTNR1AMTNR1BALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119654151-A | Composition for caring skin | 莱雅公司 | 2025-03-18 | — | — | CN | claimed |
| CN-103379911-A | PGC-1 alpha modulating peptides | LIPOTEC SA | 2013-10-30 | — | — | CN | claimed |
| US-8314069-B2 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2012-11-20 | — | — | US | claimed |
| US-20120027706-A1 | METHODS FOR TREATING SKIN PIGMENTATION | SHAPIRO STANLEY S (US) | 2012-02-02 | — | — | US | claimed |
| US-20110266517-A1 | PEPTIDE NANOSTRUCTURES ENCAPSULATING A FOREIGN MATERIAL AND METHOD OF MANUFACTURING SAME | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2011-11-03 | — | — | US | claimed |
| EP-1575867-B1 | PEPTIDE NANOSTRUCTURES, METHODS FOR THEIR PREPARATION AND USE | UNIV RAMOT (IL) | 2011-05-18 | — | — | EP | claimed |
| JP-4401441-B2 | — | — | 2010-01-20 | — | — | JP | claimed |
| CN-101421297-A | Peptides that block the binding of igg to fcrn | SYNTONIX PHARMACEUTICALS INC (US) | 2009-04-29 | — | — | CN | claimed |
| EP-1356142-B1 | NON-POSTDRAWN POLYOLEFIN FIBERS WITH HIGH TENACITY | BOREALIS GMBH (AT) | 2006-04-19 | — | — | EP | claimed |
| CN-1192747-A | Peptidyl heterocyclic compounds for the treatment of thrombin-related diseases | ORTHO PHARMA CORP (US) | 1998-09-09 | — | — | CN | claimed |
| EP-0833839-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1998-04-08 | — | — | EP | claimed |
| WO-1998011125-A1 | IMPROVED SOLID-PHASE PEPTIDE SYNTHESIS AND AGENT FOR USE IN SUCH SYNTHESIS | ZEALAND PHARMACEUTICALS A/S (DK) | 1998-03-19 | — | — | WO | claimed |
| WO-1996040741-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040742-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATEDDISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040748-A1 | PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| US-5523308-A | SERINE PROTEASES INHIBITORS; ORAL ANTICOAGULANTS; CHEMICAL INTERMEDIATES; DIPEPTIDES | ORTHO PHARMACEUTICAL CORPORATION | 1996-06-04 | — | — | US | claimed |
| US-5399570-A | Aspartic acid derivatives, and their use for inhibiting platelete aggregation | CASSELLA AKTIENGESELLSCHAFT (DE) | 1995-03-21 | — | — | US | claimed |
| US-5153236-A | Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images | HITACHI CHEMICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | claimed |
| US-4419490-A | GROUP 8 METAL | HEYL & CO. CHEMISCH-PHARMAZEUTISCHE FABRIK (DE) | 1983-12-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120027706-A1 | METHODS FOR TREATING SKIN PIGMENTATION | TYR, MC1R, NQO1 | NPSR1 3552/4885MTNR1A 255/4885MTNR1B 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.